160 related articles for article (PubMed ID: 6187789)
1. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
Cody RJ; Covit AB; Schaer GL; Laragh JH
J Am Coll Cardiol; 1983 Apr; 1(4):1154-9. PubMed ID: 6187789
[TBL] [Abstract][Full Text] [Related]
2. Clinical and hemodynamic experience with enalapril in congestive heart failure.
Cody RJ
Am J Cardiol; 1985 Jan; 55(2):36A-40A. PubMed ID: 2981464
[TBL] [Abstract][Full Text] [Related]
3. Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure.
Dunkman WB; Wilen M; Franciosa JA
Chest; 1983 Nov; 84(5):539-45. PubMed ID: 6313304
[TBL] [Abstract][Full Text] [Related]
4. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
5. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure.
Franciosa JA; Wilen MM; Jordan RA
J Am Coll Cardiol; 1985 Jan; 5(1):101-7. PubMed ID: 2981088
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN
Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045
[TBL] [Abstract][Full Text] [Related]
7. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.
DiCarlo L; Chatterjee K; Parmley WW; Swedberg K; Atherton B; Curran D; Cucci M
J Am Coll Cardiol; 1983 Nov; 2(5):865-71. PubMed ID: 6313787
[TBL] [Abstract][Full Text] [Related]
8. Immediate converting-enzyme inhibition with intravenous enalapril in chronic congestive heart failure.
Kubo SH; Cody RJ; Laragh JH; Prida XE; Atlas SA; Yuan Z; Sealey JE
Am J Cardiol; 1985 Jan; 55(1):122-6. PubMed ID: 2981462
[TBL] [Abstract][Full Text] [Related]
9. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure.
Creager MA; Massie BM; Faxon DP; Friedman SD; Kramer BL; Weiner DA; Ryan TJ; Topic N; Melidossian CD
J Am Coll Cardiol; 1985 Jul; 6(1):163-73. PubMed ID: 2989349
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic hemodynamic effects of enalapril (MK-421) in congestive heart failure.
Dickstein K; Søyland E; Gundersen T; Abrahamsen AM; Kjekshus J
Int J Cardiol; 1984 Oct; 6(4):445-58. PubMed ID: 6092286
[TBL] [Abstract][Full Text] [Related]
11. Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up.
Lin M; Chiang HT; Chang MS; Kong CW; Wang SP; Chiang BN
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jul; 48(1):31-40. PubMed ID: 1679372
[TBL] [Abstract][Full Text] [Related]
12. A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
Insel J; Mirvis DM; Boland MJ; Cinquegrani MP; Shanes J; Rubin SA; Whalen JJ
Clin Pharmacol Ther; 1989 Mar; 45(3):312-20. PubMed ID: 2537699
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.
Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
Br Heart J; 1983 Aug; 50(2):163-9. PubMed ID: 6309203
[TBL] [Abstract][Full Text] [Related]
14. Acute and long-term response to enalapril in congestive failure.
Kjekshus JK; Søyland E; Dickstein K; Abrahamsen AM; Gundersen T
Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6099734
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
Lantz P; Enghoff E; Hedlund A; Hägg A
Scand J Urol Nephrol Suppl; 1984; 79():129-32. PubMed ID: 6089312
[TBL] [Abstract][Full Text] [Related]
16. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses.
Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemeier T; Rush JE
Am Heart J; 1988 Aug; 116(2 Pt 1):480-8. PubMed ID: 2840815
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
[TBL] [Abstract][Full Text] [Related]
18. Estimation of angiotensin II receptor activity in chronic congestive heart failure.
Cody RJ; Covit AB; Schaer GL; Laragh JH
Am Heart J; 1984 Jul; 108(1):81-9. PubMed ID: 6328965
[TBL] [Abstract][Full Text] [Related]
19. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II-mediated vasoconstriction in chronic congestive heart failure, and response to converting enzyme inhibition.
Cody RJ
Am J Med; 1984 Aug; 77(2A):71-7. PubMed ID: 6089559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
